Traders bought shares of Colgate-Palmolive Co. (NYSE:CL) on weakness during trading on Thursday. $54.56 million flowed into the stock on the tick-up and $25.98 million flowed out of the stock on the tick-down, for a money net flow of $28.58 million into the stock. Of all equities tracked, Colgate-Palmolive had the 41st highest net in-flow for the day. Colgate-Palmolive traded down ($0.07) for the day and closed at $74.27

A number of research analysts have recently weighed in on the company. B. Riley reiterated a “neutral” rating and set a $71.00 price target on shares of Colgate-Palmolive in a report on Wednesday, August 3rd. JPMorgan Chase & Co. reiterated a “hold” rating and set a $75.00 price target on shares of Colgate-Palmolive in a report on Friday, July 29th. Exane BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to a “neutral” rating in a report on Friday, July 29th. Citigroup Inc. lifted their price target on Colgate-Palmolive from $82.00 to $88.00 and gave the company a “buy” rating in a report on Friday, July 29th. Finally, BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to a “neutral” rating and set a $76.00 price target on the stock. in a report on Friday, July 29th. Fourteen analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $74.04.

The firm has a 50-day moving average of $74.46 and a 200-day moving average of $71.52. The firm has a market capitalization of $66.21 billion and a price-to-earnings ratio of 47.82.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Thursday, July 28th. The company reported $0.70 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.69 by $0.01. The business had revenue of $3.85 billion for the quarter, compared to analyst estimates of $3.86 billion. The business’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.70 EPS. Equities analysts forecast that Colgate-Palmolive Co. will post $2.78 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 15th. Investors of record on Friday, July 22nd were paid a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a yield of 2.10%. The ex-dividend date was Wednesday, July 20th.

In other news, Director Stephen I. Sadove sold 8,803 shares of the firm’s stock in a transaction dated Monday, August 8th. The stock was sold at an average price of $74.28, for a total value of $653,886.84. Following the completion of the transaction, the director now owns 26,474 shares in the company, valued at approximately $1,966,488.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CTO Patricia Verduin sold 3,666 shares of the firm’s stock in a transaction dated Friday, July 15th. The shares were sold at an average price of $74.98, for a total value of $274,876.68. Following the completion of the transaction, the chief technology officer now owns 54,602 shares of the company’s stock, valued at approximately $4,094,057.96. The disclosure for this sale can be found here.

Other institutional investors recently made changes to their positions in the company. Baird Financial Group Inc. boosted its position in shares of Colgate-Palmolive by 1.0% in the fourth quarter. Baird Financial Group Inc. now owns 60,082 shares of the company’s stock valued at $4,003,000 after buying an additional 620 shares during the last quarter. American International Group Inc. boosted its position in shares of Colgate-Palmolive by 0.8% in the fourth quarter. American International Group Inc. now owns 477,500 shares of the company’s stock valued at $31,810,000 after buying an additional 3,845 shares during the last quarter. Ameriprise Financial Inc. boosted its position in shares of Colgate-Palmolive by 0.8% in the fourth quarter. Ameriprise Financial Inc. now owns 816,400 shares of the company’s stock valued at $54,386,000 after buying an additional 6,207 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. boosted its position in shares of Colgate-Palmolive by 8.3% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 3,058,290 shares of the company’s stock valued at $203,744,000 after buying an additional 233,585 shares during the last quarter.

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.